THE COMPARISON OF EFFECTIVENESS OF SLOW SPECIFIC ORAL IMMUNOTHERAPY FOR WHEAT ALLERGY USING TWO DIFFERENT INTAKE FREQUENCY
OBJECTIVE: We performed a constructive study on the effectiveness of oral immunotherapy for wheat allergy using two different intake frequency, and evaluated the impact of intake frequency.
SUBJECTS: Of all the subjects who had a positive result in an oral food challenge test for udon (wheat noodles), informed consent was obtained from 49 subjects. Forty-one of the subjects successfully completed testing; data was tabulated for only the 16 in each group who complied with their assigned intake frequency.
METHOD: Oral immunotherapy was administered after randomly dividing the subjects into the following two groups according to intake frequency: the frequent group, whose intake was six times/week or more; and the intermittent group, whose intake was two times/week. The ability of these patients to ingest the noodles at the target dose was evaluated after 6 months.
RESULTS: After six months, the proportion of subjects who had a negative result on testing with the target dose (20g dried noodle weight for subjects ≤3 years of age, and 50g dried noodle weight for those ≥4 years of age) or who were capable of the target intake within six months was 75%, and there was no difference among the both groups.
CONCLUSION: The findings suggest that even when intake frequency is reduced to twice/week, no clear difference is seen with the target dose after six months of immunotherapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
---|---|
Enthalten in: |
Arerugi = [Allergy - 65(2016), 8 vom: 01. Aug., Seite 1009-17 |
Sprache: |
Japanisch |
---|
Beteiligte Personen: |
Takaoka, Yuri [VerfasserIn] |
---|
Links: |
---|
Themen: |
37341-29-0 |
---|
Anmerkungen: |
Date Completed 03.04.2017 Date Revised 11.10.2017 published: Print Citation Status MEDLINE |
---|
doi: |
10.15036/arerugi.65.1009 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM264233077 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM264233077 | ||
003 | DE-627 | ||
005 | 20231224205634.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||jpn c | ||
024 | 7 | |a 10.15036/arerugi.65.1009 |2 doi | |
028 | 5 | 2 | |a pubmed24n0880.xml |
035 | |a (DE-627)NLM264233077 | ||
035 | |a (NLM)27616175 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a jpn | ||
100 | 1 | |a Takaoka, Yuri |e verfasserin |4 aut | |
245 | 1 | 4 | |a THE COMPARISON OF EFFECTIVENESS OF SLOW SPECIFIC ORAL IMMUNOTHERAPY FOR WHEAT ALLERGY USING TWO DIFFERENT INTAKE FREQUENCY |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.04.2017 | ||
500 | |a Date Revised 11.10.2017 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVE: We performed a constructive study on the effectiveness of oral immunotherapy for wheat allergy using two different intake frequency, and evaluated the impact of intake frequency | ||
520 | |a SUBJECTS: Of all the subjects who had a positive result in an oral food challenge test for udon (wheat noodles), informed consent was obtained from 49 subjects. Forty-one of the subjects successfully completed testing; data was tabulated for only the 16 in each group who complied with their assigned intake frequency | ||
520 | |a METHOD: Oral immunotherapy was administered after randomly dividing the subjects into the following two groups according to intake frequency: the frequent group, whose intake was six times/week or more; and the intermittent group, whose intake was two times/week. The ability of these patients to ingest the noodles at the target dose was evaluated after 6 months | ||
520 | |a RESULTS: After six months, the proportion of subjects who had a negative result on testing with the target dose (20g dried noodle weight for subjects ≤3 years of age, and 50g dried noodle weight for those ≥4 years of age) or who were capable of the target intake within six months was 75%, and there was no difference among the both groups | ||
520 | |a CONCLUSION: The findings suggest that even when intake frequency is reduced to twice/week, no clear difference is seen with the target dose after six months of immunotherapy | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Randomized Controlled Trial | |
650 | 7 | |a Allergens |2 NLM | |
650 | 7 | |a Immunoglobulin E |2 NLM | |
650 | 7 | |a 37341-29-0 |2 NLM | |
700 | 1 | |a Kameda, Makoto |e verfasserin |4 aut | |
700 | 1 | |a Yajima, Yuko |e verfasserin |4 aut | |
700 | 1 | |a Tsuji, Taisuke |e verfasserin |4 aut | |
700 | 1 | |a Nishikido, Tomoki |e verfasserin |4 aut | |
700 | 1 | |a Yoshida, Yukinori |e verfasserin |4 aut | |
700 | 1 | |a Doi, Satoru |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Arerugi = [Allergy |d 1961 |g 65(2016), 8 vom: 01. Aug., Seite 1009-17 |w (DE-627)NLM012602043 |x 0021-4884 |7 nnns |
773 | 1 | 8 | |g volume:65 |g year:2016 |g number:8 |g day:01 |g month:08 |g pages:1009-17 |
856 | 4 | 0 | |u http://dx.doi.org/10.15036/arerugi.65.1009 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 65 |j 2016 |e 8 |b 01 |c 08 |h 1009-17 |